Daiichi Sankyo to launch COVID-19 vaccine in Japan in 2022
Published
Japanese drugmaker Daiichi Sankyo Co said Thursday it expects to launch its COVID-19 vaccine in Japan by the end of 2022 after studies that started in March yielded…
Full ArticlePublished
Japanese drugmaker Daiichi Sankyo Co said Thursday it expects to launch its COVID-19 vaccine in Japan by the end of 2022 after studies that started in March yielded…
Full Article